CREB1 and Alzheimer disease: Inhibition of miR‐134‐5p using miR‐134‐5p specific antagomir (miR‐134i) upregulates the expression of CREB‐1 and BDNF which is otherwise downregulated in AD thereby, reinstating late LTP and STC in AD hippocampus.